Impact of human bladder cancer cell architecture on autologous T-lymphocyte activation

被引:31
作者
Dangles, V
Validire, P
Wertheimer, M
Richon, S
Bovin, C
Zeliszewski, D
Vallancien, G
Bellet, D
机构
[1] Inst Gustave Roussy, Dept Biol Clin, F-94805 Villejuif, France
[2] Ctr Med Montsouris, Urol Serv, Paris, France
[3] Ctr Med Montsouris, Serv Anat Pathol, Paris, France
[4] Univ Paris 05, Fac Sci Pharmaceut & Biol Paris, ESA 8067 CNRS, Lab Immunol Tumeurs, Paris, France
关键词
immune response; tumor architecture; in vitro assays; escape mechanisms;
D O I
10.1002/ijc.10140
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
To investigate the influence of tumor cell architecture on T-cell activation, we used an autologous human model based on 2 bladder tumor cell lines as targets for cytotoxic tumor-infiltrating lymphocytes (TILs). These tumor cell lines were grown in vitro as either standard 2-dimensional (213) mono-layers or 3-dimensional (3D) spheroids. T-cell activation was determined by measuring the production of three major cytokines (tumor necrosis factor, granulocyte/macrophage colony-stimulating factor and interferon-gamma), known to be secreted by most activated TILs. Changes in the architecture of target cells from 2D to 3D induced a dramatic decrease in their capacity for stimulating TILs. Interestingly, neither TIL infiltration nor MHC class 1, B7.1 costimulatory or lymphocyte function-associated factor-3 adhesion molecule down-regulation played a major role in this decrease. These findings demonstrate that tumor architecture has a major impact on T-cell activation and might be implicated in the escape of tumor cells from the immune system. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:51 / 56
页数:6
相关论文
共 29 条
[1]
Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor [J].
Armitage, JO .
BLOOD, 1998, 92 (12) :4491-4508
[2]
PRODUCTION OF MONOCLONAL ANTIBODIES TO GROUP-A ERYTHROCYTES, HLA AND OTHER HUMAN CELL-SURFACE ANTIGENS - NEW TOOLS FOR GENETIC-ANALYSIS [J].
BARNSTABLE, CJ ;
BODMER, WF ;
BROWN, G ;
GALFRE, G ;
MILSTEIN, C ;
WILLIAMS, AF ;
ZIEGLER, A .
CELL, 1978, 14 (01) :9-20
[3]
Bodey B, 2000, ANTICANCER RES, V20, P2665
[4]
Dangles V, 1997, CANCER RES, V57, P3360
[5]
A HIGHLY SENSITIVE CELL-LINE, WEHI-164 CLONE 13, FOR MEASURING CYTOTOXIC FACTOR TUMOR-NECROSIS-FACTOR FROM HUMAN-MONOCYTES [J].
ESPEVIK, T ;
NISSENMEYER, J .
JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 95 (01) :99-105
[6]
SPECIFIC RELEASE OF CYTOKINES BY LYMPHOCYTES INFILTRATING HUMAN MELANOMAS IN RESPONSE TO SHARED MELANOMA ANTIGENS [J].
HOM, SS ;
SCHWARTZENTRUBER, DJ ;
ROSENBERG, SA ;
TOPALIAN, SL .
JOURNAL OF IMMUNOTHERAPY, 1993, 13 (01) :18-30
[7]
Housseau F, 1997, INT J CANCER, V71, P585, DOI 10.1002/(SICI)1097-0215(19970516)71:4<585::AID-IJC13>3.0.CO
[8]
2-B
[9]
Multicellular spheroids:: a three-dimensional in vitro culture system to study tumour biology [J].
Kunz-Schughart, LA ;
Kreutz, M ;
Knuechel, R .
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 1998, 79 (01) :1-23
[10]
A RANDOMIZED TRIAL OF INTRAVESICAL DOXORUBICIN AND IMMUNOTHERAPY WITH BACILLE CALMETTE-GUERIN FOR TRANSITIONAL-CELL CARCINOMA OF THE BLADDER [J].
LAMM, DL ;
BLUMENSTEIN, BA ;
CRAWFORD, ED ;
MONTIE, JE ;
SCARDINO, P ;
GROSSMAN, HB ;
STANISIC, TH ;
SMITH, JA ;
SULLIVAN, J ;
SAROSDY, MF ;
CRISSMAN, JD ;
COLTMAN, CA .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (17) :1205-1209